Mechanisms of Increased Vascular Superoxide Production in an Experimental Model of Idiopathic Dilated Cardiomyopathy
- 1 December 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (12) , 2554-2559
- https://doi.org/10.1161/01.atv.0000190673.41925.9b
Abstract
Objective— In the present study, we sought to identify mechanisms underlying increased oxidative stress in vascular tissue in an experimental animal model of chronic congestive heart failure (CHF). Methods and Results— Superoxide and nitric oxide (NO) was measured in vessels from cardiomyopathic hamsters (CHF hamsters) and golden Syrian hamsters. We also determined expression of endothelial nitric oxide synthase (NOSIII), the soluble guanylyl cyclase, the cGMP-dependent kinase, and the NADPH oxidase. To analyze the contribution of the renin-angiotensin system to oxidative stress, CHF hamsters were treated with the angiotensin-converting enzyme inhibitor captopril for 200 days (120 mg · kg −1 · d −1 ). CHF led to increased superoxide production by NOSIII and the NADPH oxidase. Decreased NO production in CHF was associated with a decrease in the expression of NOSIII and an inhibition of NO downstream signaling in the aorta. NOSIII expression was increased within the left ventricle. Captopril treatment normalized NOSIII expression in vessels and the myocardium, reduced superoxide levels, and prevented NOSIII uncoupling. Accordingly, endothelial function, NO production, and downstream signaling were improved in CHF vessels. Conclusions— Oxidative stress in CHF is mediated by NADPH oxidase and an uncoupled NOSIII secondary to an activation of the renin-angiotensin system leading to impaired NO downstream signaling.Keywords
This publication has 12 references indexed in Scilit:
- Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4Free Radical Biology & Medicine, 2005
- Oxygen Free Radical Release in Human Failing Myocardium Is Associated With Increased Activity of Rac1-GTPase and Represents a Target for Statin TreatmentCirculation, 2003
- Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathyAmerican Heart Journal, 2003
- Interactions of Peroxynitrite, Tetrahydrobiopterin, Ascorbic Acid, and ThiolsJournal of Biological Chemistry, 2003
- Nebivolol Prevents Vascular NOS III Uncoupling in Experimental Hyperlipidemia and Inhibits NADPH Oxidase Activity in Inflammatory CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Vascular Oxidative Stress and Endothelial Dysfunction in Patients With Chronic Heart FailureCirculation, 2002
- Rac Activation Induces NADPH Oxidase Activity in Transgenic COS Cells, and the Level of Superoxide Production Is Exchange Factor-dependentJournal of Biological Chemistry, 2002
- Spin Trapping of Vascular Nitric Oxide Using Colloid Fe(II)-DiethyldithiocarbamateBiochemical and Biophysical Research Communications, 2000
- Validation of Lucigenin as a Chemiluminescent Probe to Monitor Vascular Superoxide as Well as Basal Vascular Nitric Oxide ProductionBiochemical and Biophysical Research Communications, 1999
- Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase.Journal of Clinical Investigation, 1992